Encompass Health Sees Raises FY24 EPS Guidance From $3.86-$4.11 To $3.97-$4.22 Vs $4.11 Est.; Revenue Guidance From $5.25B-$5.35B To $5.275B-$5.35B Vs $5.31B Est.
Portfolio Pulse from Benzinga Newsdesk
Encompass Health has raised its FY24 EPS guidance from $3.86-$4.11 to $3.97-$4.22, compared to the $4.11 estimate. The company also adjusted its revenue guidance from $5.25B-$5.35B to $5.275B-$5.35B, against the $5.31B estimate.
August 05, 2024 | 9:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Encompass Health has raised its FY24 EPS guidance to $3.97-$4.22 and revenue guidance to $5.275B-$5.35B, indicating a positive outlook compared to previous estimates.
The raised EPS and revenue guidance suggest that Encompass Health is performing better than previously expected, which is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100